Beck Bode LLC’s Bausch Health BHC Stock Holding History

Beck Bode LLC’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-500	Closed	-$15K	–	103
2021 Q2	$15K	Buy	+500	New	+$15.1K	﹤0.01%	205
2020 Q4	–	Sell	-500	Closed	-$8K	–	34
2020 Q3	$8K	Buy	+500	New	+$8.61K	﹤0.01%	219

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.26B AUM 15.11% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.63B AUM 5.11% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $58.9B AUM 51.73% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

Beck Bode LLC's BHC Position: Q3 2021 in Review

Beck Bode LLC sold out of Bausch Health (BHC) in Q3 2021, closing a stake of 500 shares — an estimated $15K sold.

Beck Bode LLC first reported a position in BHC in Q3 2020 and held it in 2 quarters. The position peaked at $15K in Q2 2021. 347 funds tracked by Wall St. Rank hold BHC as of Q3 2021.

Beck Bode LLC reported no remaining Bausch Health position as of Q3 2021 after selling out during the quarter.
Beck Bode LLC sold 500 Bausch Health shares in Q3 2021, an estimated $15K.
Beck Bode LLC first reported a position in Bausch Health in Q3 2020 and held it in 2 quarters.
Beck Bode LLC's Bausch Health position peaked at $15K in Q2 2021.
347 funds tracked by Wall St. Rank held Bausch Health as of Q3 2021.

Based on Beck Bode LLC's 13F filing for Q3 2021, filed 22 Oct 2021.